Candida albicans and Staphylococcus lugdunensis superinfection of liver cysts in a patient with autosomal dominant polycystic kidney disease under prednisolone treatment.
Administration, Oral
Aged
Anti-Bacterial Agents
/ therapeutic use
Antifungal Agents
/ therapeutic use
Candida albicans
/ isolation & purification
Cysts
/ diagnosis
Diffusion Magnetic Resonance Imaging
/ methods
Giant Cell Arteritis
/ diagnosis
Glucocorticoids
/ administration & dosage
Humans
Liver
/ pathology
Male
Polycystic Kidney, Autosomal Dominant
/ complications
Prednisolone
/ administration & dosage
Staphylococcus lugdunensis
/ isolation & purification
Superinfection
/ drug therapy
Treatment Outcome
Autosomal dominant polycystic kidney disease
Candida albicans
Candida famata
Cyst infection
Double infection
Staphylococcus lugdunensis
Journal
CEN case reports
ISSN: 2192-4449
Titre abrégé: CEN Case Rep
Pays: Japan
ID NLM: 101636244
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
19
12
2019
accepted:
09
05
2020
pubmed:
23
5
2020
medline:
7
9
2021
entrez:
23
5
2020
Statut:
ppublish
Résumé
We report a case of superinfection of liver cysts caused by Candida albicans and Staphylococcus lugdunensis in a patient with autosomal dominant polycystic kidney disease. A 69-year-old man with chief complaints of headache and blurred vision was admitted to the former institution for the evaluation of suspected temporal arteritis. He was prescribed oral prednisolone (55 mg/day) as a preemptive treatment; however, he became febrile and presented with bilateral flank pain during prednisolone tapering. Blood culture revealed fungemia as a result of Candida famata infection; thus, micafungin treatment was started. Thereafter, recrudescence of the C-reactive protein level ensued. Then a cyst infection as visualized on magnetic resonance imaging led to cyst aspiration sclerotherapy. Cyst aspirate culture revealed the presence of C. albicans in one of the cysts and S. lugdunensis in two of the cysts. The patient was clinically stabilized with an additional 3 weeks of antibiotic and antifungal drug administration.
Identifiants
pubmed: 32440858
doi: 10.1007/s13730-020-00488-4
pii: 10.1007/s13730-020-00488-4
pmc: PMC7502095
doi:
Substances chimiques
Anti-Bacterial Agents
0
Antifungal Agents
0
Glucocorticoids
0
Prednisolone
9PHQ9Y1OLM
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
370-374Références
Clin J Am Soc Nephrol. 2009 Jul;4(7):1183-9
pubmed: 19470662
Ann Intern Med. 1988 Jan;108(1):88-100
pubmed: 3276268
Case Rep Infect Dis. 2015;2015:543685
pubmed: 26605096
Clin Infect Dis. 2016 Feb 15;62(4):e1-50
pubmed: 26679628
Semin Diagn Pathol. 2017 Jul;34(4):325-331
pubmed: 28506688
Braz J Med Biol Res. 2014 Jul;47(7):584-93
pubmed: 24919173
J Antimicrob Chemother. 2013 Feb;68(2):438-43
pubmed: 23085777
Support Care Cancer. 2017 Apr;25(4):1063-1069
pubmed: 27885468
Nephron Clin Pract. 2009;112(3):c157-63
pubmed: 19390216
Mayo Clin Proc. 1990 Jul;65(7):933-42
pubmed: 2198396
Infection. 2008 Aug;36(4):314-21
pubmed: 18648747
Nihon Shokakibyo Gakkai Zasshi. 2009 Jul;106(7):1056-62
pubmed: 19578314
J Orthop Case Rep. 2017 Jan-Feb;7(1):46-49
pubmed: 28630839
J Clin Microbiol. 1991 Mar;29(3):419-21
pubmed: 2037657
Neth J Med. 2018 Jul;76(5):226-234
pubmed: 30019678